Most in the healthcare industry have begun to hear more about longevity – an area of medical science that has the ability to dramatically improve well-being for all of humanity. With the advancements in understanding human biology at the cellular level, researchers and scientists have pinpointed specific areas that can be treated to improve or extend critical bodily functions. One of the organizations that is pioneering new technology in the longevity space is Juvenescence, a biopharmaceutical company that has raised over $100 million to build a pipeline of therapeutic assets...
Sorry, you need to subscribe to read this article.
If you would like to access this article, please subscribe below.
Premium subscribers receive complete access to our site content which includes market research and insights as well as coverage of the most important news, issues and events related to the healthcare technology industry.